Scientific Core Two
Scientific Core Two
批准号:
10589644
负责人:
Marie Pancera
金额:
$48.47万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-30 至 2027-12-31
关键词:
AntibodiesAntibody FormationAntibody ResponseAntigensB-LymphocytesBindingBiochemicalComplement 4bComplexCryoelectron MicroscopyCrystallizationCyclic GMPElectron Microscopy FacilityEnzyme-Linked Immunosorbent AssayEpitopesGlycoproteinsHIV-1HIV-1 vaccineHumanImmunizationIn VitroKnock-in MouseMammalian CellMapsMembraneMessenger RNAMethodologyMethodsMonoclonal AntibodiesProductionRNA vaccineReagentRecombinant AntibodyRecombinant ProteinsRecombinantsResolutionRobotSarnaStructureUniversitiesVaccinesValidationWashingtonX-Ray Crystallographydesignenv Gene Productsenv Glycoproteinsinterestmanufacturenanoparticleneutralizing antibodyprotein complexresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Broadly neutralizing antibodies are likely to be an important component of an HIV-1 vaccine. The HIV-1 Envelope
(Env) glycoprotein is the sole target of neutralizing antibodies and has been a focus of immunogen designs. Yet
diverse recombinant (rec) Envs do not display detectable binding to the inferred germline (gl) of certain bNAbs,
such as the VRC01-class bNAbs, which are the focus of our IPCAVD project. Rec Envs capable of binding
glVRC01 bNAbs have been designed and induced the production of glVRC01 bNAbs when used as
immunogens. In this IPCAVD, we propose to determine if self-amplifying (sa) mRNA expressing our germline-
targeting 426c.Mod.Core prime and HxB2.WT.Core boost immunogens, expressed either as secreted
nanoparticles (-C4b) or membrane-anchored (gp160ΔCT), will initiate the maturation of VRC01 B cell response
in humans. The Scientific Core Two will provide high quality reagents to Scientific Projects One and Two and
Scientific Core One of this IPCAVD as well as structural information on selected vaccine-elicited Mab of interest
in complex with their antigens, to delineate their epitopes. This information will help us to better understand the
B cell response elicited by the saRNA constructs compared to rec Env immunogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies
-
批准号:10160694
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Marie Pancera
-
依托单位:
Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies
-
批准号:10374164
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2021
-
负责人:Marie Pancera
-
依托单位:
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
-
批准号:10540728
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2018
-
负责人:Marie Pancera
-
依托单位:
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
-
批准号:10062815
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2018
-
负责人:Marie Pancera
-
依托单位:
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
-
批准号:10300440
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2018
-
负责人:Marie Pancera
-
依托单位:
Recombinant HIV-1 Env glycoprotein immunogens and antibodies production and structural characterization
-
批准号:10593445
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2018
-
负责人:Marie Pancera
-
依托单位:
海外基金